Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Hematology. American Society of Hematology. Education Program|December 9, 2022
Knowledge to date on secondary malignancy following hematopoietic cell transplantation for sickle cell diseaseCourtney D Fitzhugh
Advances in Experimental Medicine and Biology|November 12, 2017
Alternative Donor/Unrelated Donor Transplants for the β-Thalassemia and Sickle Cell DiseaseCourtney D Fitzhugh, Allistair Abraham, Matthew M Hsieh
Blood Cells, Molecules & Diseases|September 13, 2017
Curative approaches for sickle cell disease: A review of allogeneic and autologous strategiesDaniel E Bauer, Christian Brendel, Courtney D Fitzhugh
Pediatric Blood & Cancer|February 11, 2005
Enalapril and hydroxyurea therapy for children with sickle nephropathyCourtney D Fitzhugh, Delbert R Wigfall, Russell E Ware
Blood|June 2, 2011
Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is nowMatthew M Hsieh, Courtney D Fitzhugh, John F Tisdale
Hematology/Oncology Clinics of North America|November 18, 2022
Allogeneic Transplant and Gene Therapy: Evolving Toward a CureR AdeBisi Lawal, Mark C Walters, Courtney D Fitzhugh
Journal of Clinical Medicine|June 10, 2022
Clonal Hematopoiesis and the Risk of Hematologic Malignancies after Curative Therapies for Sickle Cell DiseaseLukasz P Gondek, Vivien A Sheehan, Courtney D Fitzhugh
Seminars in Hematology|July 1, 2018
When there is no match, the game is not over: Alternative donor options for hematopoietic stem cell transplantation in sickle cell diseaseJacinth J Joseph, Allistair A Abraham, Courtney D Fitzhugh
Seminars in Hematology|March 23, 2016
Alternative donor allogeneic hematopoietic cell transplantation for hemoglobinopathiesFeras Alfraih, Mahmoud Aljurf, Courtney D Fitzhugh, et al.
Pageof 6